Who has invested in TScan Therapeutics?

BlackRock, RA Capital Management, Longwood Fund, 6 Dimensions Capital, Bessemer Venture Partners, GV are named among the investors backing TScan Therapeutics.

TScan Therapeutics Funding: $180M Raised, Series C (2021)

TScan Therapeutics funding overview

TScan Therapeutics is based in Waltham. TScan Therapeutics has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2021. The round record for TScan Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include BlackRock, RA Capital Management, Longwood Fund, 6 Dimensions Capital, Bessemer Venture Partners, GV and 2 others. 8 distinct backers are named across the disclosed rounds.

TScan Therapeutics at a glance

Total raised: $180M
Latest round: Series C
Latest round date: January 2021
Headquarters: Waltham
Notable investors: BlackRock, RA Capital Management, Longwood Fund, 6 Dimensions Capital, Bessemer Venture Partners, GV, Novartis Venture Fund, Pitango HealthTech

Frequently asked about TScan Therapeutics funding

How much has TScan Therapeutics raised?: TScan Therapeutics has raised $180M in total disclosed funding across the rounds on record.
Who has invested in TScan Therapeutics?: BlackRock, RA Capital Management, Longwood Fund, 6 Dimensions Capital, Bessemer Venture Partners, GV are named among the investors backing TScan Therapeutics.
What was the latest TScan Therapeutics funding round?: The most recent disclosed round is a Series C, announced in January 2021.
Where is TScan Therapeutics based?: TScan Therapeutics is based in Waltham.
When did TScan Therapeutics last raise?: The last disclosed TScan Therapeutics round closed in January 2021 at Series C.

We update the TScan Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Waltham and their backers are listed below.

TScan Therapeutics Funding: $180M Raised, Series C (2021)

TScan Therapeutics funding overview

TScan Therapeutics at a glance

Frequently asked about TScan Therapeutics funding

Companies related to TScan Therapeutics (36)

Browse related funding lists (8)